Skip to content

BCLI BRAINSTORM CELL THERAPEUTICS I

Follow

COM (common), issuer CIK 1137883

5 managers (5 13F filers) reported a position in BCLI shares at 2025-09-30, 2,317 shares in all. 0 filers opened a position and 29 filers sold out during the quarter.

Managers
5
13F filers
5
New
0
Added
0
Reduced
0
Sold out
29
Shares held by filers
2,317

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q3 2025

Filers in the available 13F reports with a share position at 2025-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
OSAIC HOLDINGS, INC.in group OSAIC HOLDINGS, INC.1,785$1.35K<0.01%013F-HRTimelineGroup
Bangor Savings Bank266$188<0.01%013F-HRTimeline
VSM Wealth Advisory, LLC120$85<0.01%013F-HRTimeline
Steward Partners Investment Advisory, L…113$80<0.01%013F-HRTimeline
ST GERMAIN D J CO INCin group ST GERMAIN D J CO INC33$23<0.01%013F-HRTimelineGroup